APOC3 Inhibition: A Novel Approach to Lowering TGs
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
FCS: Enhancing the Diagnosis
Daniel Gaudet, MD, PhD
SHTG: Defining the Unmet Clinical Need
Pam R. Taub, MD, FACC, FASPC
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
The Road Ahead: What's on the Horizon for FCS and SHTG Management
Prof. Kausik Ray
Latest Clinical Trial Outcomes and Breakthroughs for FCS
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
Faiez Zannad, MD, PhD
John McMurray, MD
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Jan T. Kielstein, MD, FASN, FERA
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function
Thor Edvardsen, MD, PhD
Understanding hypertrophic cardiomyopathy and recent guidelines
Elena Arbelo, MD, PhD
Role of echocardiography in risk stratification and treatment decision-making
Maurizio Pieroni, MD, PhD
Echo essentials for HCM: The heartbeat of diagnosis and treatment
Patient Case Study: Obesity
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Alexander T. Cohen, MD, MBBS
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.